Skip to main content
Home Licenses

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2025/02/vq-vert-color-linkedin-size.png

VQ Biomedical secures $5M, including a seed round led by Harbright, WIN, and DCP

VQ Biomedical is a Duke University start-up and DCP portfolio company resulting from the collaboration Duke clinicians and engineers.

Read More

https://otc.duke.edu/wp-content/uploads/2025/02/vq-biomedical-story-featured-image-v2.png

Breath of Life: Duke Inventors Secure $5M for Novel Oxygenation Startup

Duke clinician partners with Duke engineers to tackle an elusive critical care challenge: Can oxygen be delivered directly into the bloodstream through a catheter?

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/autm-2025-hill-visit-featured-image.png

Colleagues off the Court: Duke and UNC Champion Research and Innovation on Capitol Hill

From Google’s search to 3D printing, from MRIs to mRNA vaccines, countless products and services that make our lives better started as university born innovations from research.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/avalo-logo-featured-image.png

Durham agtech startup Avalo secures $11M in funding

Avalo is a Duke agtech start-up based on technology developed by former postdoc Mariano Alvarez (Biology, Trinity) and Professor Cynthia Rudin (CS, Trinity).

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/mchutchison-featured.png

Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board

New Tune CEO John McHutchison has held professorships and associate directorships at SOM and DCRI. Tune is a Duke spinout and DCP portfolio company.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/lumotive-logo-featured-image.png

Lumotive Raises $45 Million to Expand Sales of Programmable Optical Semiconductors

Lumotive is a metamaterials start-up spun out of the labs of Professor David Smith and Associate Professor Maiken Mikkelsen (ECE, Pratt). Mikkelsen's former postdoc Gleb Akselrod is the founder and CTO.

Read More

https://otc.duke.edu/wp-content/uploads/2025/01/jim-flatt-wide.png

Dr. Jim Flatt Announced as New CEO of DMC Biotechnologies

DMC Technologies is a Duke start-up commercializing sustainable chemistry technology out of the lab of Associate Professor Michael Lynch (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2025/01/tune-therapeutics-large.png

Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs

Tune Therapeutics is a Duke University start-up and Duke Capital Partners portfolio company developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/humacyte-logo-new.png

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

Humacyte is a Duke University start-up out of the lab of Dr. Laura Niklason (formerly Anesthesiology, SOM), co-founded with Drs. Juliana Blum and Shannon Dahl.

Read More

1 2 3 14